by Alex Kadhim
A new Blood study identifies recipient endothelial IFNγ-IRF1 signaling as a critical regulator of immune tolerance after allogeneic hematopoietic cell transplantation, promoting regulatory T-cell...
by Alex Kadhim
A multicenter Engraft Learning Health Network study reveals significant variation in chronic graft-versus-host disease screening practices after allogeneic hematopoietic cell transplantation,...
by Alex Kadhim
New research identifies NLRP6 as a critical regulator of donor T-cell activity after allogeneic hematopoietic cell transplantation, showing that loss of NLRP6 worsens acute graft-versus-host...
by Alex Kadhim
New research identifies donor-cell GATA3 as a key driver of intestinal graft-versus-host disease after hematopoietic cell transplantation, linking it to pathogenic T-cell activity, tissue damage,...
by Alex Kadhim
Published in Blood Advances, researchers from the MIDAS consortium, including Roswell Park Comprehensive Cancer Center, The Ohio State University, Cincinnati Children’s Medical Center, and...
by Alex Kadhim
Researchers at The University of Texas MD Anderson Cancer Center have demonstrated that permissive human leukocyte antigen (HLA)-DPB1 mismatches can reduce relapse after matched unrelated donor...